Drug Type Shared antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms WT1 W10 |
Target |
Action modulators |
Mechanism WT1 modulators(Wilms' Tumour 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myelodysplastic Syndromes | Phase 2 | Japan | 11 Sep 2009 | |
Glioblastoma | Phase 2 | - | - | |
Glioblastoma | Phase 2 | - | - | |
Glioma | Phase 1 | Japan | - | - |
Pancreatic Cancer | Clinical | Japan | - | - |